EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuncel, G.
Right arrow Articles by Kadiogullari, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuncel, G.
Right arrow Articles by Kadiogullari, N.
Related Collections
Right arrow Anesthesia
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2005;28:375-379
© 2005 Elsevier Science NL


Original articles

Epidural ropivacaine or sufentanil–ropivacaine infusions for post-thoracotomy pain{star}

Gonca Tuncel * , Gulcin Ozalp, Serpil Savli, Ozgur Canoler, Mensure Kaya, Nihal Kadiogullari

Department of Anaesthesiology, Ankara Oncology Hospital, Ankara, Turkey

Received 23 February 2005; received in revised form 13 May 2005; accepted 16 May 2005.

* Corresponding author. Address: Birlik mah. 5. Cad. Yali apt. No: 27/3, 06610 Çankaya/Ankara, Turkey. Tel.: +90 312 495 85 57; fax: +90 312 345 49 79. (Email: goncatuncel{at}hotmail.com).

Abstract

Objective: The aim of this study was to compare the analgesic efficacy and side effects of continuous epidural infusions of ropivacaine and ropivacaine–sufentanil mixtures after thoracotomy. Methods: Sixty-two patients scheduled for thoracic surgery were allocated in this prospective double-blinded randomised study. They received an epidural catheter inserted from thoracic 5–6 (Th5–6) interspace a day before surgery and were randomly assigned into two groups, sufentanil–ropivacaine group (Group SR, n=31) and ropivacaine group (Group R, n=31). Bolus dose of the study drugs, ropivacaine 0.2% or ropivacaine 0.2% and sufentanil 0.75µg/ml calculated in ml according to the patient's height was given through the epidural catheter before surgery. One hour after anaesthesia induction, another bolus was given and the epidural infusion was started (4.5–8ml). Whenever visual analogue scale (VAS) scores were ≥4 during function, the patients received additional boluses and the infusion rate was increased by 1ml/h. If the pain was not relieved after administration of two boluses, the patient was excluded from the study. Results: VAS at rest and during function was lower in ropivacaine–sufentanil group and the need for additional boluses and infusion rate increase was high in ropivacaine group (P<0.05). Ropivacaine–sufentanil infusion rate was decreased due to nausea and vomiting in two patients and due to CO2 retention in one patient. There was no statistically significant difference between the incidences of side effects except pruritus significantly higher in Group SR. The total epidural solution volume was more in Group R (P<0.05). Conclusions: The continuous epidural infusion of ropivacaine with sufentanil provided superior pain relief than ropivacaine alone without causing any severe side effect or post-operative pulmonary impairment.

Key Words: Thoracotomy • Epidural analgesia • opioid • Sufentanil • Local anaesthetic • Ropivacaine







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.